Myelofibrosis (MF) is a chronic myeloproliferative neoplasm which can lead to massive
splenomegaly secondary to extramedullary hematopoiesis. Patients frequently exhibit …

Cirrhosis is the most common cause of portal hypertension but there are many causes of
noncirrhotic portal hypertension. Many of these etiologies may be diagnosed by liver biopsy …

The liver is involved in many multisystem diseases and commonly may manifest with
abnormal liver chemistry tests. The liver test perturbations may be multifactorial in nature …

Herein is reported a series of five patients with myeloid neoplasms presenting hepatic
complications in whose liver biopsy revealed obstruction of sinusoids by platelet aggregates …

Abstract Background and Aim Obliterative portal venopathy (OPV) is one of the causes of
non‐cirrhotic portal hypertension. However, many aspects of OPV remain unclear, including …

Ruxolitinib is increasingly being utilized for the treatment of myelofibrosis and polycythemia
vera, but the potential for hepatic toxicity is poorly understood. We performed a retrospective …

Abstract Purpose of Review The development of portal hypertension is typically a
consequence of liver cirrhosis due mainly to primary liver disorders, whereas non-cirrhotic …

Abstract Purposeof Review To review the clinical and histopathological features of
obliterative portal venopathy (OPV). Recent Findings OPV is one cause of non-cirrhotic …

Idiopathic portal hypertension (IPH) is defined as the presence of portal hypertension in the
absence of a common cause. IPH can have several etiologies, one of which is a genetic …

Нецирротическая портальная гипертензия (НЦПГ) достаточно распространенное
заболевание, в патогенезе которого лежит венозное поражение печени. Основными …